Results 41 to 50 of about 31,350 (256)
Pregabalin for neuropathic pain in adults.
Cochrane Database of Systematic Reviews, 2019 BACKGROUND This review updates part of an earlier Cochrane Review titled "Pregabalin for acute and chronic pain in adults", and considers only neuropathic pain (pain from damage to nervous tissue).
S. Derry +5 more
semanticscholar +1 more source
Pain and Therapy, 2021 This study was performed to explore the efficacy and safety of pregabalin and gabapentin in patients with spinal cord injury (SCI)-induced neuropathic pain to determine which treatment is most suitable for such patients.
Chen Tong +5 more
semanticscholar +1 more source
Sub chronic Toxicity of Pregabalin and Possible Fibrotic Changes in Ovaries, Kidneys, Heart, and Lungs of Female Rats [PDF]
Zagazig Journal of Forensic Medicine and Toxicology, 2022 Background: Pregabalin is an anti-epileptic drug that was approved as neuropathic pain therapy. Incidence of adverse Background: Pregabalin is an anti-epileptic drug that was approved as neuropathic pain therapy.
Noha Ebrahem +4 more
doaj +1 more source
Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration
Postgraduate medicine, 2021 Pregabalin is one of the first-line treatments approved for the management of neuropathic pain (NeP). While many patients benefit from treatment with pregabalin, they are often treated with suboptimal doses, possibly due to unfamiliarity around ...
R. Freynhagen +11 more
semanticscholar +1 more source
Frontiers in Pain ResearchIntroduction Neuropathic pain is a prevalent and burdensome condition, and both pregabalin and gabapentin are widely used for its treatment. However, there is a lack of clarity regarding their comparative efficacy and safety.
V. Mayoral +7 more
semanticscholar +1 more source
Bulletin of Faculty of Pharmacy Cairo UniversityPregabalin is a γ-aminobutyric acid analogue used for the treatment of neuropathic pain, seizures, and anxiety disorders. After oral administration, its level of brain penetration is rather modest. In this research, pregabalin was formulated successfully
Hend Fayez +3 more
doaj +1 more source
Reactions Weekly, 2018 Pregabalin is a second-generation antiepileptic drug characterized by few antiepileptic indications, with a very good interaction profile in polytherapy. The therapeutic indications of pregabalin for the treatment of epileptic seizures have been largely overshadowed by its widespread use for the treatment of anxiety disorders (especially generalized ...
C. Vidal, W.-R. Külpmann
+5 more sources
Involvement of the dopaminergic system in the reward-related behavior of pregabalin
Scientific Reports, 2021 There has been an increase in cases of drug addiction and prescription drug abuse worldwide. Recently, pregabalin abuse has been a focus for many healthcare agencies, as highlighted by epidemiological studies.
Yusuf S. Althobaiti +14 more
doaj +1 more source
Healthcare, 2021 Pregabalin is a first-line therapy for neuropathic pain and for chronic pain. It has abuse potential. This study was conducted to assess community pharmacists’ perceptions towards pregabalin abuse and misuse in the Aseer region, Saudi Arabia, and ...
Sultan M. Alshahrani +3 more
semanticscholar +1 more source
Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies
Saudi Pharmaceutical Journal, 2018 Objectives: Pregabalin is currently approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain and fibromyalgia. Rising attention to the abuse liability of pregabalin causing addictive behaviors is partially based on case ...
Amneh Al-Husseini +3 more
doaj +1 more source